covid
Buscar en
Revista Colombiana de Anestesiología
Toda la web
Inicio Revista Colombiana de Anestesiología Coagulopatía temprana en trauma: ¿Llegan los pacientes coagulopáticos a la sa...
Información de la revista
Vol. 38. Núm. 4.
Páginas 510-525 (noviembre - enero 2010)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 38. Núm. 4.
Páginas 510-525 (noviembre - enero 2010)
ARTÍCULO DE REVISIÓN
Open Access
Coagulopatía temprana en trauma: ¿Llegan los pacientes coagulopáticos a la sala de cirugía?
Early Coagulopathy in Trauma
Visitas
8153
Juan Carlos Jiménez B.
, Jairo de La Peña L.**, Rubén Teherán M.***, Andrés Orozco****
* MD Especialista en Anestesiología, Universidad de Cartagena. Anestesiólogo Hospital Universitario del Caribe, Cartagena, Colombia
** Residente de I año Cirugía General, Universidad de Cartagena, Cartagena, Colombia
*** MD. Anestesiólogo director UCI Hospital Universitario del Caribe, Cartagena, Colombia
**** Médico de Planta, UCI Hospital Universitario del Caribe, Cartagena, Colombia
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
RESUMEN
Introducción

De la coagulopatía aguda en el trauma, resultan múltiples complicaciones como la necesidad de administración de hemoderivados, mayor incidencia de disfunción orgánica, aumento de estancia en unidad de cuidados intensivos y mayor mortalidad. Con el conocimiento actual de la fisiopatología del trauma y la vía celular de la coagulación es ahora posible mejorar el dignóstico y tratamiento de la coagulopatía inicial y conseguir mejores resultados en nuestros centros.

Métodos

Este artículo examina la fisiología básica de la coagulación, la etiología, el diagnóstico y el tratamiento de la coagulopatía temprana en trauma. La búsqueda se realizó con términos Mesh y no Mesh con conectores AND: Anesthesia-coagulophaty, postinjury and trauma thromboelastography, transfusion and trauma, shock- Mechanism and trauma review.

Resultados

La coagulopatía aguda o temprana en trauma está directamente asociada al estado de shock y se caracteriza por anticoagulación e hiperfibrinolisis sistémica; hay evidencia de la implicación de la proteína C en este proceso. Se ha establecido que seis mecanismos fisiopatológicos multifactoriales pueden perpetuar la coagulopatía en los pacientes traumatizados; éstos son: inflamación, acidosis, hipotermia, shock, trauma tisular y hemodilución. El diagnóstico se realiza con las diferentes pruebas (TP, TPT, plaquetas) ya conocidas desde hace mucho tiempo, pero con limitaciones que reducen su utilidad clínica. Ahora la tromboelastografía nos puede ayudar a guiar la transfusión, con el concepto actual de transfusión temprana de glóbulos rojos, plasma y plaquetas, utilizando la mejor proporción según la evidencia disponible.

Conclusiones

Contamos, con algún conocimiento sobre la fisiopatología de la coagulopatía asociada con trauma pero son necesarias más investigaciones, en este campo. El diagnóstico rápido y una intervención directa inmediata son importantes para mejorar el desenlace de nuestros pacientes.

Palabras claves:
Coagulopatía
trauma
hemorragia
transfusión
tromboelastografía (Fuente: DeCS, BIREME)
SUMMARY
Introduction

Acute coagulopathy in trauma results in multiple complications such as the need for blood products, higher rates of organ dysfunction, longer stay in the ICU and higher mortality. With the current knowledge of the pathophysiology of trauma and of the cellular coagulation pathway it is now possible to improve diagnosis and treatment of the initial coagulopathy and achieve better outcomes in our trauma centers.

Methods

This paper looks into the basic physiology of coagulation, and the etiology, diagnosis and treatment of early coagulopathy in trauma. The search was done using Mesh and non-Mesh terms with AND connectors: Anesthesia-coagulopathy, postinjury and trauma thromboelastography, transfusion and trauma, shock-Mechanism and trauma review.

Results

Acute or early coagulopathy in trauma is directly associated with a state of shock and is characterized by anticoagulation and systemic hyperfibrinolysis; protein C is known to be implicated in this process. It has also been determined that six multi-factorial pathophysiological mechanisms may perpetuate coagulopathy in trauma patients, namely, inflammation, acidosis, hypothermia, shock, tissue trauma and hemodilution. Diagnosis is made using the different tests (PT, PPT, platelets) that have been in use for a long time; however, these tests have drawbacks that limit their clinical usefulness. Thromboelastography can now help guide early transfusion using the best proportion of red blood cells, plasma and platelets on the basis of the best available evidence.

Conclusions

We have some knowledge about the pathophysiology coagulopathy associated with trauma but more research in this field is needed. Rapid diagnosis and immediate intervention are important to improve the outcomes with our patients.

Keywords:
Coagulopathy
trauma
hemorrhage
transfusion
thromboelastography (Source: MeSH, BIREME)
El Texto completo está disponible en PDF
REFERENCES
[1.]
K. Brohi, J. Mitchell, Cohenb, A. Ross.
Davenporta. Acute coagulopathy of trauma: mechanism, identification and effect.
Curr Opin Crit Care, 13 (2007), pp. 680-685
[2.]
A. Charles, A.A. Shaikh, M. Walters, S. Huehl, R. Pomerantz.
Bloodtransfusion is an independent predictor of mortality after blunttrauma.
Am Surg, 73 (2007), pp. 1-5
[3.]
B.S. Kheirabadi, J.M. Crissey, R. Deguzman, J.B. Holcomb.
In vivobleeding time and in vitro thrombelastography measurements are better indicators of dilutional hypothermic coagulopathy thanprothrombin time.
J Trauma, 62 (2007), pp. 1352-1359
[4.]
L. Rugeri, A. Levrat, J.S. David, et al.
Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography.
JThrombHaemost, 5 (2007), pp. 289-295
[5.]
M.A. Borgman, P.C. Spinella, J.G. Perkins, et al.
The ratio of bloodproducts transfused affects mortality in patients receiving massive transfusions at a combat support hospital.
J Trauma, 63 (2007), pp. 805-813
[6.]
A. Sauaia, F.A. Moore, E.E. Moore, et al.
Epidemiology of trauma deaths: a Reassessment.
J Trauma, 38 (1995), pp. 185-193
[7.]
J.B. MacLeod, M. Lynn, M. McKenney, S. Cohn, M. Murtha.
Early coagulopathy predicts mortality in trauma.
[8.]
K. Brohi, J. Singh, M. Heron, T. Coats.
Acute traumatic coagulopathy.
J. Trauma, 54 (2003), pp. 1127-1130
[9.]
P.F. Stahel, E.E. Moore, S.L. Schreier, M.A. Flierl, J.L. Kashuk.
Transfusion Strategies in Posinjury Coagulophaty.
Curr Opin Anesth, 22 (2009), pp. 289-298
[10.]
K. Brohi, M.J. Cohen, M.T. Ganter, et al.
Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis.
J Trauma, 64 (2008), pp. 1211-1217
[11.]
K. Brohi, M.J. Cohen, M.T. Ganter, et al.
Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?.
[12.]
J.C. Torres, M.U. Torres, M.A. Benjumea.
Manejo de hemorragia digestiva profusa secundaria a hemangioma intestinal con factorVIIa recombinante [Reporte de caso y revisión de la literatura].
Act Colom de Cuid Inten, 8 (2008), pp. 322-329
[13.]
Tanaka, A. kenichi, N.S. Keil, Levy, H. Jerrold.
Blood Coagulation: Hemostasis and Thrombin Regulation.
Anesth. & Analg, 108 (2009), pp. 1433-1446
[14.]
R.H. John, K. Brohi, P.D. Richard, J.H. Carl, B.H. John, Y. Kluger, K. Mackway, M. Par, S.B. Rizoli, T. Yukioka, D.B. Hoyt, B. Bouillon.
The Coagulopathy of Trauma: A Review of Mechanisms.
J Trauma, 65 (2008), pp. 748-754
[15.]
C.T. Esmon.
The interactions between inflammation and coagulation.
Bj J Haematol, 131 (2005), pp. 417-430
[16.]
K.G. Mann.
Biochemistry and physiology of blood coagulation.
Thromb Haemost, 82 (1999), pp. 165-174
[17.]
J.H. Siegel, A.I. Rivkind, S. Dalal, et al.
Early physiologic predictors of injur Severity and death in blunt multiple trauma.
Arch Surg, 125 (1990), pp. 498-508
[18.]
Z.K. Brummel, M.F. Whelihan, E.G. Ziedins, K.G. Mann.
Theresuscitative fluid you choose may potentiate bleeding.
[19.]
A.M. Ho, M.K. Karmakar, P.W. Dion.
Are we giving enough coagulation factors during major trauma resuscitation?.
Am J Surg, 190 (2005), pp. 479-484
[20.]
A. Hirshberg, M. Dugas, E.I. Banez, B.G. Scott, M.J. Wall, K.L. Mattox.
Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation.
[21.]
E.V. Brazil, T.J. Coats.
Sonoclot coagulation analysis of in-vitro haemodilution with resuscitation solutions.
J R Soc Med, 93 (2000), pp. 507-510
[22.]
J.L. Vincent, R. Rossaint, B. Riou, Y. Ozier, D. Zideman, D.R. Spahn.
Recommendations on the use of rFVIIa as an adjunctive treatment for massive bleeding -a European perspective.
Critical Care, 10 (2006), pp. R120
[23.]
R.L. Reed II, A.W. Bracey Jr., J.D. Hudson, T.A. Miller, R.P. Fischer.
Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels.
Circ Shock, 32 (1990), pp. 141-152
[24.]
A.S. Wolberg, Z.H. Meng, D.M. Monroe III, M. Hoffman.
A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function.
J Trauma, 56 (2004), pp. 1221-1228
[25.]
Z.H. Meng, A.S. Wolberg, D.M. Monroe III, M. Hoffman.
The effect oftemperature and pH on the activity of factor VIIa: implications forthe efficacy of high-dose factor VIIa in hypothermic and acidoticpatients.
[26.]
A.S. Wolberg, Z.H. Meng, D.M. Monroe, M.A. Hoffman.
systematic evaluation ofthe effect of temperature on coagulation enzyme activity and platelet function.
J Trauma, 56 (2004), pp. 1221-1228
[27.]
W.Z. Martini, A.E. Pusateri, J.M. Uscilowicz, A.V. Delgado, J.B. Holcomb.
Independent contributions of hypothermia and acidosis tocoagulopathy in swine.
J Trauma [discussion], 58 (2005), pp. 1009-1010
[28.]
N. Cosgriff, E.E. Moore, A. Sauaia, K. Moynihan, J.M. Burch, B. Galloway.
Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited.
J Trauma. [discussion], 42 (1997), pp. 857-861
[29.]
W.Z. Martini, M.A. Dubick, C.E. Wade, J.B. Holcomb.
Evaluation of tris-hydroxymethyl aminomethane on reversing coagulation abnormalities caused by acidosis in pigs.
Crit Care Med, 35 (2007), pp. 1568-1574
[30.]
M. Levi, T. van der Poll, H. ten Cate, S.J. van Deventer.
The cytokine mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia.
Eur J Clin Invest, 27 (1997), pp. 3-9
[31.]
R.J. Shebuski, K.S. Kilgore.
Role of inflammatory mediators in thrombogenesis.
J Pharmacol Exp Ther, 300 (2002), pp. 729-735
[32.]
B.B. Chesebro, P. Rahn, M. Carles, C. Esmon, X. Jun, K. Brohi, D. Frith, J.-P. Pittet, M. Cohen.
Increase in activated protein c mediates acute traumatic coagulopathy in mice.
Shock, 6 (2009 Dec 32), pp. 659-665
[33.]
L. Rugeri, A. Levrat, J.S. David, et al.
Diagnosis of early coagulation abnormalitiesin trauma patients by rotation thrombelastography.
J Thromb Haemost, 5 (2007), pp. 289-295
[34.]
R.A. Devenport, K. Brohi.
Coagulophaty in trauma patients : Importance of thrombocyte function?.
Curr Opin Anesth, 22 (2009), pp. 261-266
[35.]
M. Oliver, D.R Theusinger, M. Ganter.
Transfusion in trauma: why and how should we change our current practice?.
Curr Opn Anaesth, 22 (2009), pp. 000
[36.]
D.V. Feliciano, K. Mattox, E. Moore.
Trauma, 6th Edition, McGraw-Hill, (2008),
[37.]
R.P. Dutton.
Current Concepts in Hemorrhagic Shock.
Anesth Clinics, 25 (2007 March 1), pp. 23-34
[38.]
American College of Surgeons Committee on Trauma.
Advanced Trauma Life Support(ATLS)Course for Physicians, edn 7,
[39.]
B. Sorensen, J. Ingerslev.
Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography.
[Suppl] Haemophilia, 11 (2005), pp. 1-6
[40.]
R.B. Brown, J. Klar, D. Teres, S. Lemeshow, M. Sands.
Prospective study of clinical bleeding in intensive care unit patients.
Crit Care Med, 16 (1988 Dec), pp. 1171-1176
[41.]
D. Stein, R. Dutton, M. Kramer, T. Scalea.
Reversal of Coagulopathy in Critically Ill Patients With Traumatic Brain Injury: recombinant Factor VIIa is More Cost-Effective Than Plasma.
[42.]
D.A. Galvan, M.P. Fink.
Recombinant factor VIIa in severe trauma: Further study needed.
Crit care, 10 (2006), pp. 308
[43.]
U. Martinowitz, J.B. Holcomb, A.E. Pusateri, et al.
Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine ith grade V liver injuries.
J Trauma, 50 (2001), pp. 721-729
[44.]
C. Bartal, A. Yitzha.
The role of thromboelastometry and recombinant factor VIIa in trauma.
Curr Opin Anaesthesiol, 22 (2009 Apr), pp. 281-288
[45.]
P. Hellstern, W.M. Halbmayer, M. Kohler, et al.
Prothrombin complex concentrates: indications, contraindications, and risks: a task force summary.
Thromb Res, 95 (1999), pp. S3-S6
[46.]
B. Blauhut.
Indications for prothrombin complex concentrates in massive transfusions.
Thromb Res, 95 (1999), pp. S63-S69
[47.]
S. Schulman, N.R. Bijsterveld.
Anticoagulants and their reversal.
Transfusion Medicine Reviews, 21 (2007), pp. 37-48
[48.]
S.Q. Van Veen, P.F. Strengers.
Use of prothrombin complex concentrates in anticoagulation.
Am J Hematol, 83 (2008), pp. 344-345
[49.]
C.T. Esmon.
Crosstalk between inflammation and thrombosis.
[50.]
A.C. Rigby, M.A. Grant.
Protein S: a conduit between anticoagulation and inflammation.
Crit Care Med, 32 (2004), pp. S336-S341
Copyright © 2010. Revista Colombiana de Anestesiología
Descargar PDF
Opciones de artículo